• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
WU Yiling, YOU Qi, WU Jie. Therapeutic effect of oral vaccine based on glutamate decarboxylase 65 on streptozotocin-induced type 1 diabetic mice[J]. Journal of China Pharmaceutical University, 2021, 52(5): 614-621. DOI: 10.11665/j.issn.1000-5048.20210515
Citation: WU Yiling, YOU Qi, WU Jie. Therapeutic effect of oral vaccine based on glutamate decarboxylase 65 on streptozotocin-induced type 1 diabetic mice[J]. Journal of China Pharmaceutical University, 2021, 52(5): 614-621. DOI: 10.11665/j.issn.1000-5048.20210515

Therapeutic effect of oral vaccine based on glutamate decarboxylase 65 on streptozotocin-induced type 1 diabetic mice

More Information
  • Received Date: March 23, 2021
  • Revised Date: May 16, 2021
  • To investigate the therapeutic effect of oral vaccine based on glutamate decarboxylase 65 (GAD65) on streptozotocin (STZ) -induced type 1 diabetic (T1D) mice, the mice model of T1D was established by intraperitoneal injection of low dose multiple STZ. CTB-GADIII encapsulated with calcium alginate (Ca-Alg-GADIII) was formulated using crosslinking technology with sodium alginate and calcium chloride, and was administered intragastric to T1D mice once a week for 5 consecutive weeks.Blood glucose and body weight of the mice were recorded weekly, and pharmacodynamics against T1D of Ca-Alg-GADIII were investigated by glucose tolerance assay (OGTT) and pancreatic histopathological analysis. The levels of glutamic acid decarboxylase antibody (GADA), and insulin autoantibody (IAA) and related cytokines (IL-4, IFN-γ, TGF-β1) in serum were detected by ELISA, and the CD4 + T cell subsets were detected by flow cytometry. The immunological mechanism of oral vaccine against T1D was preliminarily discussed. The results showed that the disease-related indicators improved in immunized mice: fasting blood glucose improved, glucose tolerance and insulin secretion increased, pancreatic injury decreased, autoantibodies like GADA and IAA titers significantly decreased, and CD4 + T cell immune balance in mesenteric lymph node (MLN) and pancreatic lymph node (PLN) improved to some extent. The results suggest that oral vaccine Ca-Alg-GADIII has some therapeutic effect on STZ-induced T1D mice.
  • [1]
    . Front Immunol,2018,9:392.
    [2]
    Arneth B,Arneth R,Shams M. Metabolomics of type 1 and type 2 diabetes[J]. Int J Mol Sci,2019,20(10):2467.
    [3]
    Rolandsson O,Hampe CS,Sharp SJ,et al. Autoimmunity plays a role in the onset of diabetes after 40 years of age[J]. Diabetologia,2020,63(2):266-277.
    [4]
    Tisch R,Yang XD,Liblau RS,et al. Administering glutamic acid decarboxylase to NOD mice prevents diabetes[J]. J Autoimmun,1994,7(6):845-850.
    [5]
    Yamamoto T,Yamato E,Tashiro F,et al. Development of autoimmune diabetes in glutamic acid decarboxylase 65 (GAD65) knockout NOD mice[J]. Diabetologia,2004,47(2):221-224.
    [6]
    Casas R,Dietrich F,Barcenilla H,et al. Glutamic acid decarboxylase injection into lymph nodes:beta cell function and immune responses in recent onset type 1 diabetes patients[J]. Front Immunol,2020,11:564921.
    [7]
    Ludvigsson J. Autoantigen treatment in type 1 diabetes:unsolved questions on how to select autoantigen and administration route[J]. Int J Mol Sci,2020,21(5):1598.
    [8]
    Wang HQ,Zhang HY,Yang J,et al. Preparation of a glutamate decarboxylase 65-related peptide fusion protein and its efficacy in the treatment of type 1 diabetes mellitus[J]. Pharm Biotechnol(药物生物技术),2009,16(4):296-301.
    [9]
    Chen YL,Wu J,Wang JJ,et al. Targeted delivery of antigen to intestinal dendritic cells induces oral tolerance and prevents autoimmune diabetes in NOD mice[J]. Diabetologia,2018,61(6):1384-1396.
    [10]
    Wu J,Liu XR,Yang X,et al. Hypoglycemic effect of Lactococcus lactis vaccine containing HSP65-6P277 on streptozotocin-induced type 1 diabetic mice[J]. J China Pharm Univ(中国药科大学学报),2014,45(1):106-110.
    [11]
    Li M,Wang Y,Sun Y,et al. Mucosal vaccines:strategies and challenges[J]. Immunol Lett,2020,217:116-125.
    [12]
    Xu H,Hu FQ,Ying XY,et al. Preparation of insulin-loaded sodium alginate nanoparticles and its pharmacodynamics study on diabetic rats[J]. Chin Pharm J(中国药学杂志),2006,41(6):434-437.
    [13]
    Yang JHM,Khatri L,Mickunas M,et al. Phenotypic analysis of human lymph nodes in subjects with new-onset type 1 diabetes and healthy individuals by flow cytometry[J]. Front Immunol,2019,10:2547.
    [14]
    Abdel-Moneim A,Bakery HH,Allam G. The potential pathogenic role of IL-17/Th17 cells in both type 1 and type 2 diabetes mellitus[J]. Biomedecine Pharmacother,2018,101:287-292.
    [15]
    Zheng ZH,Zheng F. A complex auxiliary:IL-17/Th17 signaling during type 1 diabetes progression[J]. Mol Immunol,2019,105:16-31.
    [16]
    Tavira B,Barcenilla H,Wahlberg J,et al. Intralymphatic glutamic acid decarboxylase-alum administration induced Th2-like-specific immunomodulation in responder patients:a pilot clinical trial in type 1 diabetes[J]. J Diabetes Res,2018,2018:9391845.
    [17]
    Turner MS,Isse K,Fischer DK,et al. Low TCR signal strength induces combined expansion of Th2 and regulatory T cell populations that protect mice from the development of type 1 diabetes[J]. Diabetologia,2014,57(7):1428-1436.
    [18]
    Bellemore SM,Nikoopour E,Schwartz JA,et al. Preventative role of interleukin-17 producing regulatory T helper type 17 (Treg 17) cells in type 1 diabetes in non-obese diabetic mice[J]. Clin Exp Immunol,2015,182(3):261-269.
    [19]
    Clark M,Kroger CJ,Ke Q,et al. The role of T cell receptor signaling in the development of type 1 diabetes[J]. Front Immunol,2020,11:615371.
  • Related Articles

    [1]ZHOU Yongmei, TANG Cheng, ZHANG Sifang. Isolation and identification of antitumor constituents from Trichosanthes tricuspidata[J]. Journal of China Pharmaceutical University, 2019, 50(1): 46-52. DOI: 10.11665/j.issn.1000-5048.20190106
    [2]YE Feng, LYU Qinglin, ZHU Wanfang, FENG Feng, ZHANG Jie. Chemical constituents from the leaves of Anisopus mannii and the melanogenesis inhibitory activities[J]. Journal of China Pharmaceutical University, 2018, 49(6): 676-681. DOI: 10.11665/j.issn.1000-5048.20180606
    [3]ZHOU Yongmei, SHI Xianming, MA Lei, ZHANG Sifang. Isolation and identification of Withaphysalins from Physalis minima[J]. Journal of China Pharmaceutical University, 2015, 46(1): 62-65. DOI: 10.11665/j.issn.1000-5048.20150107
    [4]WANG Guoyan, ZHU Jingjing, LOU Fengchang. Chemical constituents from the exopleura of Ginkgo biloba and inhibition test of total ginkgolic acids against phytopathogenic fungi[J]. Journal of China Pharmaceutical University, 2014, 45(2): 170-174. DOI: 10.11665/j.issn.1000-5048.20140207
    [5]YIN Minmin, YIN Zhiqi, ZHANG Jian, WANG Lei, YE Wencai. Chemical constituents from ethyl acetate extract of Cynanchum otophyllum Schneid.[J]. Journal of China Pharmaceutical University, 2013, 44(3): 213-218. DOI: 10.11665/j.issn.1000-5048.20130305
    [6]LIU Zhi-yong, NIU Zhi-yuan, ZHENG Wei, SHEN Ping-ping. Effects of p-ERK1/2 on nitric oxide donor induced apoptosis of HepG2 cells[J]. Journal of China Pharmaceutical University, 2012, 43(6): 530-534.
    [7]RAO Ya-kun, DING Li, YU Yong. Structural identification of two major impurities in sodium levofolinate[J]. Journal of China Pharmaceutical University, 2012, 43(4): 350-354.
    [8]Study on the Chemical Constituents from the Leaves of Desmos chinensis Lour[J]. Journal of China Pharmaceutical University, 2003, (6): 22-24.
    [9]Effects of E6, a Calmodulin Antagonist, on Nitric Oxide Synthase in Rat''''s Brain and [3H]-Glutamic Acid Release from Synaptosome[J]. Journal of China Pharmaceutical University, 2002, (5): 81-85.
    [10]Advances in the Research of Nitric Oxide and Its Modulators[J]. Journal of China Pharmaceutical University, 2001, (5): 3-10.
  • Cited by

    Periodical cited type(0)

    Other cited types(1)

Catalog

    Article views (122) PDF downloads (404) Cited by(1)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return